ANI Pharmaceuticals, Inc. (ANIP) earnings per share (EPS)

Earnings per share · fiscal 2025
$3.32

ANI Pharmaceuticals, Inc. (ANIP) reported diluted earnings per share of $3.32 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.04. Figures as of 17 Nov 2026, 19:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$3.32
Growth, 10 years
+9.7% a year
Highest on record
$3.32fiscal 2025
Lowest on record
-$50.40fiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ANI Pharmaceuticals, Inc. earnings per share (EPS), in more detail

Over the ten fiscal years to 2025 diluted earnings per share grew at a compound 9.7% a year. Across the 17 fiscal years on record (2009–2025), the highest was $3.32 in fiscal 2025 and the lowest -$50.40 in fiscal 2009.

History · 17 fiscal years

Earnings per share by fiscal year

ANI Pharmaceuticals, Inc. earnings per share (EPS), year by year

ANI Pharmaceuticals, Inc. (ANIP) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$3.32—
2024-$1.04 222.4% down
2023$0.85—
2022-$3.05—
2021-$3.40—
2020-$1.88 476.0% down
2019$0.50 61.5% down
2018$1.30—
2017-$0.09 126.5% down
2016$0.34 74.2% down
2015$1.32 49.0% down
2014$2.59—
2013-$0.92—
2012-$7.62—
2011-$18.90—
2010-$25.26—
2009-$50.40—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

More on ANIP

ANI Pharmaceuticals, Inc., figure by figure

ANI Pharmaceuticals, Inc. (ANIP) overview: price, valuation and scorecard

ANI Pharmaceuticals, Inc. earnings per share (EPS): questions and answers

What is ANI Pharmaceuticals, Inc.'s diluted earnings per share?

ANI Pharmaceuticals, Inc. (ANIP) reported diluted earnings per share of $3.32 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.04.

What is the growth rate of ANI Pharmaceuticals, Inc.'s diluted earnings per share?

Over the ten fiscal years to 2025 diluted earnings per share grew at a compound 9.7% a year.

What are the highest and lowest diluted earnings per share figures on record for ANI Pharmaceuticals, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $3.32 in fiscal 2025 and the lowest -$50.40 in fiscal 2009.

How is ANI Pharmaceuticals, Inc.'s diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ANI Pharmaceuticals, Inc. (ANIP) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/ANIP/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.